Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
BIRMINGHAM, United Kingdom, July 7, 2026 Healome Therapeutics, a University of Birmingham spinout developing an innovative eye-drop matrix technology...
NEW YORK, July 7, 2026 Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing...
RESEARCH TRIANGLE PARK, N.C., June 16, 2026 Simulations Plus, a global leader in model-informed and AI-accelerated drug development software,...
SHANGHAI, China, June 15, 2026 CARsgen Therapeutics Holdings Limited has unveiled encouraging clinical data for its investigational allogeneic CAR...
NEW YORK and ATHENS, Greece, June 13, 2026 Kos Biotechnology Partners has announced the successful third closing of its...
Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...
Milan, Italy, May 22, 2026 A consortium led by CVC Capital Partners IX and Groupe Bruxelles Lambert (GBL) has...
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
